Therapeutic Effects of Anti-PD1 Immunotherapy on Hepatocellular Carcinoma Under Administration of Tacrolimus.
Sign Up to like & getrecommendations! Published in 2022 at "Transplantation"
DOI: 10.1097/tp.0000000000004425
Abstract: BACKGROUND Liver transplantation (LT) is the treatment of choice for patients with hepatocellular carcinoma (HCC). Recurrence of HCC after LT occurs in 10% to 20% of cases. Preclinical studies to evaluate immune checkpoint inhibitors in… read more here.
Keywords: pd1 blockade; hcc; transplantation; treatment ... See more keywords
Adalimumab plus topical tacrolimus for the treatment of pyoderma gangrenosum: Report of a case
Sign Up to like & getrecommendations! Published in 2019 at "International Wound Journal"
DOI: 10.1111/iwj.13123
Abstract: Dear Editors, A 57 years old Caucasian male, attending the outpatient of University Hospital Federico II of Naples, section of Dermatology, presented to our attention in June 2018 with a painful ulcerated lesion characterised by… read more here.
Keywords: plus topical; treatment pyoderma; adalimumab plus; pyoderma gangrenosum ... See more keywords
Evaluating Efficacy and Safety of Tacrolimus Treatment in Membranous Nephropathy: Results of a Retrospective Study of 182 Patients.
Sign Up to like & getrecommendations! Published in 2023 at "Therapeutics and clinical risk management"
DOI: 10.2147/tcrm.s399218
Abstract: Purpose Tacrolimus is recommended by KDIGO Clinical Practice Guidelines as an initial therapy for the treatment of membranous nephropathy (MN). However, little is known about the factors that influence response and recurrence of the disease… read more here.
Keywords: treatment membranous; 182 patients; membranous nephropathy; tacrolimus ... See more keywords